Literature DB >> 10535871

The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.

C Schultsz1, F M Van Den Berg, F W Ten Kate, G N Tytgat, J Dankert.   

Abstract

BACKGROUND & AIMS: Whether the bacterial flora contributes to the pathogenesis of inflammatory bowel disease (IBD) by increased penetration in mucus, increased adherence to epithelial cells, or invasion of the epithelium is unknown. We therefore studied the spatial distribution of bacteria in the mucosa of rectal biopsy specimens from patients with IBD and from controls.
METHODS: Rectal biopsy specimens from 19 patients with IBD and from 14 controls were studied by using nonradioactive ribosomal RNA in situ hybridization. Total mucosal surface length examined for each patient was measured, and the number of bacteria visualized was estimated semiquantitatively.
RESULTS: No bacteria were observed in biopsy specimens from 10 controls (71%) and 6 IBD patients (32%) (P = 0.04; odds ratio, 5.42; 95% confidence interval, 1.23-23.9). IBD rectal specimens contained significantly more bacteria than control samples (P = 0.004). Bacteria were localized within the mucus layer but did not adhere to the epithelial cells and were not present within the lamina propria. There was no correlation between the numbers of bacteria present and either the degree of inflammation or the use of anti-inflammatory agents or sulfasalazine compounds.
CONCLUSIONS: The intestinal mucus in IBD patients is less protective against the endogenous microflora than in controls, resulting in increased association of luminal bacteria with the mucus layer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535871     DOI: 10.1016/s0016-5085(99)70393-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  83 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells.

Authors:  F Sierro; B Dubois; A Coste; D Kaiserlian; J P Kraehenbuhl; J C Sirard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Probiotics and functional foods in gastrointestinal disorders.

Authors:  M H Floch; J Hong-Curtiss
Journal:  Curr Gastroenterol Rep       Date:  2001-08

5.  Fate of goblet cells in experimental colitis.

Authors:  Mireille K Makkink; Nicole M J Schwerbrock; Michael Mähler; Jos A Boshuizen; Ingrid B Renes; Markus Cornberg; Hans J Hedrich; Alexandra W C Einerhand; Hans A Büller; Siegfried Wagner; Marie-Luise Enss; Jan Dekker
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

6.  Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients.

Authors:  Katia La Ferla; Dirk Seegert; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

7.  Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.

Authors:  S J Langlands; M J Hopkins; N Coleman; J H Cummings
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

9.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.